UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

79  A survey of horse longevity and retirement in the equine assisted services industry

Journal of equine veterinary science, 2021-05, Vol.100, p.103542, Article 103542

2021

Volltextzugriff (PDF)

469 Soluble fiber in equine diets alters fecal characteristics

Journal of animal science, 2018-12, Vol.96 (suppl_3), p.250-250

2018

Volltextzugriff (PDF)

Soluble fiber in equine diets alters fecal characteristics

Journal of animal science, 2018-12, Vol.96, p.250-250

2018

Volltextzugriff (PDF)

PSI-16 Exploring the relationship between digesta retention time in the equine gastrointestinal tract and compartment models

Journal of animal science, 2018-12, Vol.96 (suppl_3), p.64-64

2018

Volltextzugriff (PDF)

Exploring the relationship between digesta retention time in the equine gastrointestinal tract and compartment models

Journal of animal science, 2018-12, Vol.96, p.64-64

2018

Volltextzugriff (PDF)

134 The Influence of a Rider with a Disability on the Equine Walk

Journal of animal science, 2016-02, Vol.94 (suppl_1), p.65-65

2016

Volltextzugriff (PDF)

Effects of Lactanase on the plasma lactate response to intense exercise in horses

Comparative exercise physiology, 2020-10, Vol.16 (5), p.409-414

2020

Volltextzugriff (PDF)

Effect of crude protein on fiber digestibility of a warm-season forage-based diet in mature horses

Journal of equine veterinary science, 2019-05, Vol.76, p.67-68

2019

Volltextzugriff (PDF)

Ammonia emissions from equine facilities in the Mid-Atlantic region

Journal of equine veterinary science, 2017-05, Vol.52, p.102-102

2017

Volltextzugriff (PDF)

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

The Lancet (British edition), 2008-07, Vol.372 (9633), p.117-126

2008

Volltextzugriff (PDF)

Clenbuterol plasma concentrations after therapeutic administration in fit Standardbred horses: threshold recommendations

Comparative exercise physiology, 2021-06, Vol.17 (4), p.343-350

2021

Volltextzugriff (PDF)

Genome‐wide association study of genetic predictors of anti–tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci

Arthritis & rheumatology (Hoboken, N.J.), 2011-03, Vol.63 (3), p.645-653

2011

Volltextzugriff (PDF)

Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis

Annals of the rheumatic diseases, 2009-01, Vol.68 (1), p.69-74

2009

Volltextzugriff (PDF)

Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis

Human molecular genetics, 2008-11, Vol.17 (22), p.3532-3538

2008

Volltextzugriff (PDF)

Assessment of long-term safety and efficacy of etanercept in a 5-year extension study in patients with rheumatoid arthritis

Clinical and experimental rheumatology, 2011-03, Vol.29 (2), p.238

2011

Volltextzugriff (PDF)

Report from the task force on surgeon-industry relationships in the discipline of orthopaedic surgery

Journal of bone and joint surgery. American volume, 2012-06, Vol.94 (12), p.e89

American Orthopaedic Association Orthopaedic Institute of Medicine Task Force on Surgeon-Industry Relationships in the Discipline of Orthopaedic Surgery

2012

Volltextzugriff (PDF)

Investigation of genetic variants within candidate genes of the TNFRSF1B signalling pathway on the response to anti-TNF agents in a UK cohort of rheumatoid arthritis patients

Pharmacogenetics and genomics, 2009-04, Vol.19 (4), p.319-323

2009

Volltextzugriff (PDF)

In vitro Study on Synergistic Interactions Between Free and Encapsulated Q-Griffithsin and Antiretrovirals Against HIV-1 Infection

International journal of nanomedicine, 2021-01, Vol.16, p.1189-1206

2021

Volltextzugriff (PDF)

Sustained-release Griffithsin nanoparticle-fiber composites against HIV-1 and HSV-2 infections

Journal of controlled release, 2020-05, Vol.321, p.84-99

2020

Volltextzugriff (PDF)

Formulation and characterization of pressure-assisted microsyringe 3D-printed scaffolds for controlled intravaginal antibiotic release

International journal of pharmaceutics, 2023-06, Vol.641, p.123054-123054, Article 123054

2023

Volltextzugriff (PDF)

Rapid-Release Griffithsin Fibers for Dual Prevention of HSV-2 and HIV-1 Infections

Antimicrobial agents and chemotherapy, 2020-05, Vol.64 (6)

2020

Volltextzugriff (PDF)

pH-responsive delivery of Griffithsin from electrospun fibers

European journal of pharmaceutics and biopharmaceutics, 2019-05, Vol.138, p.64-74

2019

Volltextzugriff (PDF)

Griffithsin-Modified Electrospun Fibers as a Delivery Scaffold To Prevent HIV Infection

Antimicrobial agents and chemotherapy, 2016-11, Vol.60 (11), p.6518-6531

2016

Volltextzugriff (PDF)

Computational Modeling of Antiviral Drug Diffusion from Poly(lactic-co-glycolic-acid) Fibers and Multicompartment Pharmacokinetics for Application to the Female Reproductive Tract

Molecular pharmaceutics, 2018-04, Vol.15 (4), p.1534-1547

2018

Volltextzugriff (PDF)

A novel, nitric oxide-releasing elastomeric chain for antimicrobial action: proof of concept

Materials research express, 2021-09, Vol.8 (9), p.95309

2021

Volltextzugriff (PDF)

1 – 25 von 171

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieThe New England Journal Of Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(154)

Publikationsform

Sprache

Englisch
(171)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

79  A survey of horse longevity and retirement in the equine assisted services industry

469 Soluble fiber in equine diets alters fecal characteristics

Soluble fiber in equine diets alters fecal characteristics

PSI-16 Exploring the relationship between digesta retention time in the equine gastrointestinal tract and compartment models

Exploring the relationship between digesta retention time in the equine gastrointestinal tract and compartment models

134 The Influence of a Rider with a Disability on the Equine Walk

Effects of Lactanase on the plasma lactate response to intense exercise in horses

Effect of crude protein on fiber digestibility of a warm-season forage-based diet in mature horses

Ammonia emissions from equine facilities in the Mid-Atlantic region

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

Clenbuterol plasma concentrations after therapeutic administration in fit Standardbred horses: threshold recommendations

Genome‐wide association study of genetic predictors of anti–tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci

Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis

Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis

Assessment of long-term safety and efficacy of etanercept in a 5-year extension study in patients with rheumatoid arthritis

Report from the task force on surgeon-industry relationships in the discipline of orthopaedic surgery

Investigation of genetic variants within candidate genes of the TNFRSF1B signalling pathway on the response to anti-TNF agents in a UK cohort of rheumatoid arthritis patients

In vitro Study on Synergistic Interactions Between Free and Encapsulated Q-Griffithsin and Antiretrovirals Against HIV-1 Infection

Sustained-release Griffithsin nanoparticle-fiber composites against HIV-1 and HSV-2 infections

Formulation and characterization of pressure-assisted microsyringe 3D-printed scaffolds for controlled intravaginal antibiotic release

Rapid-Release Griffithsin Fibers for Dual Prevention of HSV-2 and HIV-1 Infections

pH-responsive delivery of Griffithsin from electrospun fibers

Griffithsin-Modified Electrospun Fibers as a Delivery Scaffold To Prevent HIV Infection

Computational Modeling of Antiviral Drug Diffusion from Poly(lactic-co-glycolic-acid) Fibers and Multicompartment Pharmacokinetics for Application to the Female Reproductive Tract

A novel, nitric oxide-releasing elastomeric chain for antimicrobial action: proof of concept

Aktive Filter

Suchergebnisse filtern